An intriguing question that arises from this work is why T-SCLC is primarily associated with amplification of MYC [11,13,23], whereas all MYC family members (MYC, MYCN and MYCL) are routinely amplified in de novo SCLC [23,59,60,66,69]. The gene discussed is MYC; the disease is small cell lung carcinoma.